IDH3A and acute myeloid leukemia: As might be expected, heterozygous mutations in the catalytic arginine residues of isocitrate dehydrogenase gene (IDH1/2) are common in gliomas and acute myeloid leukemia, and contribute to the pathogenesis of several tumors [30].